Published in Neurobiol Aging on June 02, 2004
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem (2009) 3.66
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
Progress and challenges in the automated construction of Markov state models for full protein systems. J Chem Phys (2009) 2.64
Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A (2009) 2.50
On the nucleation of amyloid beta-protein monomer folding. Protein Sci (2005) 2.47
Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging (2007) 2.13
Amyloid beta-protein monomer structure: a computational and experimental study. Protein Sci (2006) 1.99
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol Aging (2007) 1.99
Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest (2005) 1.96
Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils. J Neurosci (2010) 1.92
Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci (2008) 1.75
Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences. J Mol Biol (2008) 1.62
Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging (2007) 1.58
Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus. Proc Natl Acad Sci U S A (2007) 1.55
Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. Proc Natl Acad Sci U S A (2004) 1.53
Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J Biol Chem (2009) 1.52
Structure of the 21-30 fragment of amyloid beta-protein. Protein Sci (2006) 1.51
Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation. Biophys J (2007) 1.48
Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS One (2008) 1.46
Folding events in the 21-30 region of amyloid beta-protein (Abeta) studied in silico. Proc Natl Acad Sci U S A (2005) 1.43
Solvent and mutation effects on the nucleation of amyloid beta-protein folding. Proc Natl Acad Sci U S A (2005) 1.37
Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J (2006) 1.35
Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J Biol Chem (2008) 1.33
Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35. Biophys J (2006) 1.33
Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization. J Am Chem Soc (2009) 1.30
Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol (2009) 1.30
How is protein aggregation in amyloidogenic diseases modulated by biological membranes? Eur Biophys J (2007) 1.29
Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Curr Alzheimer Res (2008) 1.26
An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer's disease. Proc Natl Acad Sci U S A (2005) 1.25
Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study. Biophys J (2007) 1.22
Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies. J Alzheimers Dis (2008) 1.22
Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol (2011) 1.20
Impact of amyloid imaging on drug development in Alzheimer's disease. Nucl Med Biol (2007) 1.19
Targeting Abeta and tau in Alzheimer's disease, an early interim report. Exp Neurol (2009) 1.18
Discovery and characterization of a mammalian amyloid disaggregation activity. Protein Sci (2010) 1.13
Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins. J Cell Mol Med (2007) 1.13
Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS One (2008) 1.13
Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Abeta species on lipid bilayers. Biochemistry (2010) 1.13
Insight into amyloid structure using chemical probes. Chem Biol Drug Des (2011) 1.10
Amino acid position-specific contributions to amyloid beta-protein oligomerization. J Biol Chem (2009) 1.10
Stable and metastable states of human amylin in solution. Biophys J (2010) 1.08
Amyloid β-protein oligomers and Alzheimer's disease. Alzheimers Res Ther (2013) 1.07
Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ. Proc Natl Acad Sci U S A (2013) 1.06
The Japanese mutant Aβ (ΔE22-Aβ(1-39)) forms fibrils instantaneously, with low-thioflavin T fluorescence: seeding of wild-type Aβ(1-40) into atypical fibrils by ΔE22-Aβ(1-39). Biochemistry (2011) 1.05
Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity. Proc Natl Acad Sci U S A (2009) 1.04
Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med (2009) 1.03
Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial. J Neurosci (2013) 1.02
A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging (2013) 1.02
Single-cell mechanics provides a sensitive and quantitative means for probing amyloid-beta peptide and neuronal cell interactions. Proc Natl Acad Sci U S A (2010) 1.02
Dimer formation enhances structural differences between amyloid β-protein (1-40) and (1-42): an explicit-solvent molecular dynamics study. PLoS One (2012) 1.01
Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases. Alzheimers Res Ther (2009) 1.00
Two distinct amyloid beta-protein (Abeta) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses. J Biol Chem (2011) 1.00
Behavior of neural stem cells in the Alzheimer brain. Cell Mol Life Sci (2008) 0.98
Amyloid-β triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One (2010) 0.98
Modulation of Abeta42 low-n oligomerization using a novel yeast reporter system. BMC Biol (2006) 0.97
Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity. J Biol Chem (2012) 0.96
Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem. Front Neurol (2013) 0.96
Allopregnanolone promotes regeneration and reduces β-amyloid burden in a preclinical model of Alzheimer's disease. PLoS One (2011) 0.95
Fluorescent Arc/Arg3.1 indicator mice: a versatile tool to study brain activity changes in vitro and in vivo. J Neurosci Methods (2009) 0.95
The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology. J Biol Chem (2009) 0.94
A differential association of Apolipoprotein E isoforms with the amyloid-β oligomer in solution. Proteins (2011) 0.94
CSF Biomarkers for Alzheimer's Disease Diagnosis. Int J Alzheimers Dis (2010) 0.94
NMDA-receptor activation but not ion flux is required for amyloid-beta induced synaptic depression. PLoS One (2013) 0.92
Synthesis and Purification of Highly Hydrophobic Peptides Derived from the C-Terminus of Amyloid β-Protein. Open Biotechnol J (2008) 0.92
Pulsed hydrogen-deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation. Proc Natl Acad Sci U S A (2013) 0.91
Structural basis for Aβ1–42 toxicity inhibition by Aβ C-terminal fragments: discrete molecular dynamics study. J Mol Biol (2011) 0.91
Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents. Neurobiol Aging (2008) 0.90
Oxidative stress in neurodegenerative diseases. Neural Regen Res (2012) 0.90
Mutational analysis of preamyloid intermediates: the role of his-tyr interactions in islet amyloid formation. Biophys J (2014) 0.89
A molecular dynamics study of the early stages of amyloid-beta(1-42) oligomerization: the role of lipid membranes. Proteins (2010) 0.89
A multiscale approach to characterize the early aggregation steps of the amyloid-forming peptide GNNQQNY from the yeast prion sup-35. PLoS Comput Biol (2011) 0.89
An update on the amyloid hypothesis. Neurol Clin (2007) 0.87
Role of small oligomers on the amyloidogenic aggregation free-energy landscape. J Mol Biol (2009) 0.87
Dynamics of metastable β-hairpin structures in the folding nucleus of amyloid β-protein. J Phys Chem B (2012) 0.87
Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. PLoS One (2013) 0.86
Discrete molecular dynamics study of oligomer formation by N-terminally truncated amyloid β-protein. J Mol Biol (2013) 0.86
Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28). J Biol Inorg Chem (2008) 0.86
Nanomaterials: amyloids reflect their brighter side. Nano Rev (2011) 0.86
The amyloid beta ion channel hypothesis of Alzheimer's disease. Neuropsychiatr Dis Treat (2007) 0.86
Redox proteomics in some age-related neurodegenerative disorders or models thereof. NeuroRx (2006) 0.86
Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. J Biomed Biotechnol (2006) 0.86
Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein. Int J Alzheimers Dis (2011) 0.85
β-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species. J Biol Chem (2014) 0.84
GNNQQNY--investigation of early steps during amyloid formation. Biophys J (2010) 0.84
Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there? Expert Rev Neurother (2006) 0.84
Structural Insight into an Alzheimer's Brain-Derived Spherical Assembly of Amyloid β by Solid-State NMR. J Am Chem Soc (2015) 0.84
Polyglutamine-rich suppressors of huntingtin toxicity act upstream of Hsp70 and Sti1 in spatial quality control of amyloid-like proteins. PLoS One (2014) 0.83
The influence of spin-labeled fluorene compounds on the assembly and toxicity of the aβ peptide. PLoS One (2012) 0.83
Advances on the understanding of the origins of synaptic pathology in AD. Curr Genomics (2007) 0.83
Zn2+-Aβ40 complexes form metastable quasi-spherical oligomers that are cytotoxic to cultured hippocampal neurons. J Biol Chem (2012) 0.83
Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol Neurodegener (2014) 0.83
The mechanism for heme to prevent Aβ(1-40) aggregation and its cytotoxicity. J Biol Inorg Chem (2011) 0.82
Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease. J Neural Transm (Vienna) (2007) 0.82
Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols. FASEB J (2012) 0.81
Atomic and dynamic insights into the beneficial effect of the 1,4-naphthoquinon-2-yl-L-tryptophan inhibitor on Alzheimer's Aβ1-42 dimer in terms of aggregation and toxicity. ACS Chem Neurosci (2013) 0.81
Ascidians: an invertebrate chordate model to study Alzheimer's disease pathogenesis. Dis Model Mech (2010) 0.80
Membrane permeation induced by aggregates of human islet amyloid polypeptides. Biophys J (2013) 0.80
Exploring the influence of EGCG on the β-sheet-rich oligomers of human islet amyloid polypeptide (hIAPP1-37) and identifying its possible binding sites from molecular dynamics simulation. PLoS One (2014) 0.79
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
A cellular gene encodes scrapie PrP 27-30 protein. Cell (1985) 8.86
Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature (1992) 7.16
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci (2001) 5.29
Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem (1997) 5.07
On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A (1996) 4.75
Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem (1999) 4.64
Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci (1999) 3.92
Homologies between signal transducing G proteins and ras gene products. Science (1984) 3.85
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry (1993) 3.54
Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A (1997) 3.40
Electroblotting onto activated glass. High efficiency preparation of proteins from analytical sodium dodecyl sulfate-polyacrylamide gels for direct sequence analysis. J Biol Chem (1986) 3.33
Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J Mol Biol (2001) 3.26
Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem (1995) 3.20
Neuronal development in the Drosophila retina: monoclonal antibodies as molecular probes. Cell (1984) 3.02
Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem (2001) 2.77
Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep (2001) 2.70
Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem (1995) 2.68
Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem (1988) 2.35
Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem (1996) 2.34
Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem (1997) 2.33
Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurol (1995) 2.33
Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus. J Biol Chem (1996) 2.19
In silico study of amyloid beta-protein folding and oligomerization. Proc Natl Acad Sci U S A (2004) 2.13
Isolation and characterization of a cDNA clone for the gamma subunit of bovine retinal transducin. Proc Natl Acad Sci U S A (1984) 2.12
beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem (1993) 2.01
Cloning and characterization of the myelin basic protein gene from mouse: one gene can encode both 14 kd and 18.5 kd MBPs by alternate use of exons. Cell (1985) 1.98
Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis (1997) 1.92
Generation of amyloid beta protein from its precursor is sequence specific. Neuron (1995) 1.82
Interaction of distinct domains in Mu transposase with Mu DNA ends and an internal transpositional enhancer. Nature (1989) 1.82
Temperature dependence of amyloid beta-protein fibrillization. Proc Natl Acad Sci U S A (1998) 1.78
The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. Ann N Y Acad Sci (1996) 1.67
An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments. Amyloid (2000) 1.56
Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem (1994) 1.54
Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry (1998) 1.54
Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc Natl Acad Sci U S A (1986) 1.46
A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase. J Biol Chem (2000) 1.41
Sequence homology of the LFA-1 and Mac-1 leukocyte adhesion glycoproteins and unexpected relation to leukocyte interferon. Nature (1985) 1.39
Elucidation of amyloid beta-protein oligomerization mechanisms: discrete molecular dynamics study. J Am Chem Soc (2010) 1.38
Biosynthesis and membrane topography of the neural cell adhesion molecule L1. EMBO J (1985) 1.34
Gene regulatory factors of the sea urchin embryo. I. Purification by affinity chromatography and cloning of P3A2, a novel DNA-binding protein. Development (1991) 1.34
Monitoring protein assembly using quasielastic light scattering spectroscopy. Methods Enzymol (1999) 1.32
Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A (1994) 1.31
A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat Struct Biol (2000) 1.31
Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses. Virology (1986) 1.31
Structural domains in phage Mu transposase: identification of the site-specific DNA-binding domain. Proc Natl Acad Sci U S A (1987) 1.29
Identification of the active site tyrosine of Flp recombinase. Possible relevance of its location to the mechanism of recombination. J Biol Chem (1990) 1.27
Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study. Biophys J (2007) 1.22
Identification of cDNA clones of the mouse neural cell adhesion molecule L1. Neurosci Lett (1987) 1.18
Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog. J Biol Chem (1992) 1.15
RecA protein of Escherichia coli and chromosome partitioning. Mol Microbiol (1992) 1.14
Polarized secretion of beta-amyloid precursor protein and amyloid beta-peptide in MDCK cells. Proc Natl Acad Sci U S A (1994) 1.12
Ecomycins, unique antimycotics from Pseudomonas viridiflava. J Appl Microbiol (1998) 1.10
Cryptocandin, a potent antimycotic from the endophytic fungus Cryptosporiopsis cf. quercina. Microbiology (1999) 1.09
Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study. J Am Chem Soc (2008) 1.09
Pseudomycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity. J Gen Microbiol (1991) 1.09
Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol (1995) 1.07
Identification of cellular proteins binding to the scrapie prion protein. Biochemistry (1990) 1.06
In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease. Biochem J (2001) 1.06
Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules. Ann N Y Acad Sci (1993) 1.02
beta-Amyloid, protein processing and Alzheimer's disease. Arzneimittelforschung (1995) 1.02
Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex. J Biol Chem (1996) 1.00
The vacuolar H(+)-ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type beta-amyloid precursor protein. J Biol Chem (1995) 0.98
A new peptide in the FMRFamide family isolated from the CNS of the hawkmoth, Manduca sexta. Peptides (1990) 0.98
Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch. Proc Natl Acad Sci U S A (2000) 0.96
Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein. Biochem J (1999) 0.95
Microscale structure analysis of a high-molecular-weight, hydrophobic membrane glycoprotein fraction with platelet-derived growth factor-dependent kinase activity. J Chromatogr (1986) 0.95
Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S. Biochem J (1995) 0.94
Metabolism of the "Swedish" amyloid precursor protein variant in Madin-Darby canine kidney cells. J Biol Chem (1994) 0.94
Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF. Neuron (1996) 0.93
Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation. J Biol Chem (1994) 0.93
High performance liquid chromatographic separation of the globin chains of non-human hemoglobins. Hemoglobin (1985) 0.92
Oligomerizaiton and fibril asssembly of the amyloid-beta protein. Biochim Biophys Acta (2000) 0.90
Domain of a yeast site-specific recombinase (Flp) that recognizes its target site. Proc Natl Acad Sci U S A (1991) 0.90
Dynamics of metastable β-hairpin structures in the folding nucleus of amyloid β-protein. J Phys Chem B (2012) 0.87
In vitro phosphorylation of mouse osteopontin expressed in E. coli. Biochem Biophys Res Commun (1993) 0.84
Identification of a peptide fragment from the carboxyl-terminal extension region (E-domain) of rat proinsulin-like growth factor-II. J Biol Chem (1985) 0.83
A partial genomic DNA clone for the alpha subunit of the mouse complement receptor type 3 and cellular adhesion molecule Mac-1. Proc Natl Acad Sci U S A (1986) 0.81
Identity of PSA purified from seminal fluid by different methods: comparison by amino acid analysis and assigned extinction coefficients. Prostate (1995) 0.79
Antibodies to amyloid beta protein (A beta) crossreact with glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Neurobiol Aging (1996) 0.79
Imaging as a tool for improving length and accuracy of sequence analysis in automated fluorescence-based DNA sequencing. Electrophoresis (1991) 0.78
Escherichia coli cells lacking methylation-blocking factor (leucine-responsive regulatory protein) have precise timing of initiation of DNA replication in the cell cycle. J Bacteriol (1992) 0.77
Phylogenetically conserved amino acids of MBP and P0 from amphibian myelin. J Mol Neurosci (1992) 0.76
Generation of DM-20 splice site in myelin proteolipid protein gene: a hypothesis based on analysis of the amphibian protein. Pept Res (1992) 0.75
Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C. J Mol Neurosci (1993) 0.75
New instrumentation facilitates the study of genes coding for molecules involved in cell surface recognition. Adv Exp Med Biol (1984) 0.75
Unusual phylogenetic conservation of the N-terminal amino acid sequence of the central nervous system-specific membrane glycoprotein F3-87-8 (CNSgp130). J Neurochem (1986) 0.75